Lupoxa OD Tablet SR contains Oxaceprol 600 mg as its active ingredient, formulated as a sustained-release oral dosage form to provide prolonged therapeutic effects. Oxaceprol is a non-steroidal anti-inflammatory drug (NSAID) with antioxidant properties, primarily indicated for the management of osteoarthritis and other musculoskeletal disorders characterized by inflammation and pain. The sustained-release formulation allows for once-daily dosing, enhancing patient compliance by maintaining steady plasma concentrations over an extended period. Oxaceprol exerts its pharmacological action by inhibiting the synthesis of pro-inflammatory mediators, thereby reducing inflammation, pain, and joint stiffness. Additionally, it scavenges free radicals, contributing to its protective effects on cartilage and connective tissue. Lupoxa OD Tablet SR is typically prescribed to alleviate symptoms associated with degenerative joint diseases, including pain relief and improvement in joint mobility. It is generally well-tolerated, with a lower incidence of gastrointestinal side effects compared to traditional NSAIDs due to its unique chemical structure and antioxidant activity. Caution is advised in patients with known hypersensitivity to Oxaceprol or other NSAIDs, and it should be used under medical supervision in individuals with renal or hepatic impairment. Regular monitoring is recommended during prolonged therapy to ensure safety and efficacy.